The activation of transcription relies on interactions between specific transcription factors and general transcription regulators that can mediated by transcriptional co-activators (Fuda et al., 2009) . It is important to characterize these interactions because their inhibition by small molecules or other biological tools offers opportunities for therapeutic intervention in many disease areas, including oncology (Darnell, 2002) . Since they involve intrinsically disordered transactivation domains the associated complexes are however transient, marginally stable and challenging to study (Wright and Dyson, 2015) .
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The activation of transcription relies on interactions between specific transcription factors and general transcription regulators that can mediated by transcriptional co-activators (Fuda et al., 2009) . It is important to characterize these interactions because their inhibition by small molecules or other biological tools offers opportunities for therapeutic intervention in many disease areas, including oncology (Darnell, 2002) . Since they involve intrinsically disordered transactivation domains the associated complexes are however transient, marginally stable and challenging to study (Wright and Dyson, 2015) .
One case where inhibiting these interactions is appealing is castration resistant prostate cancer (CRPC). This condition is suffered by prostate cancer patients that are refractory to hormone therapy, which is based on preventing the activation of the androgen receptor (AR). The mechanisms that allow cell proliferation under these conditions are not yet fully characterized but it is becoming clear that they include expression of constitutively active AR isoforms lacking the ligand binding domain (Miyamoto et al., 2015; Robinson et al., 2015) .
The complexes formed by the transactivation domain of AR (Lavery and McEwan, 2008a) and general transcription regulators are targets to interfere with CRPC (Sadar, 2011) because inhibiting their formation can lead to a decrease in AR transcriptional activity and in the proliferation of prostate cancer cells. Here we report the structural basis for the interaction of the transactivation domain of AR and the C-terminal domain of subunit 1 of the general transcription regulator TFIIF (RAP74-CTD), which involves the partial folding upon binding of a ca 10-residue motif in this receptor and contributes to the initiation of transcription (Choudhry et al., 2006; McEwan and Gustafsson, 1997) .
Results

A motif in transcriptional activation unit 5 of AR adopts a helical conformation to recruit RAP74-
CTD
To identify the regions of the AR involved in recruiting RAP74-CTD we used solution nuclear magnetic resonance (NMR). NMR is appropriate for characterizing protein-protein interactions involving intrinsically disordered proteins because it provides residue-specific information in the absence of the long-range order required for crystallization (Dyson and Wright, 2004) . In addition, it is well-suited for the characterization of weak protein-protein interactions, which can occur when one of the partners is intrinsically disordered (Wright and Dyson, 2009 ).
We used a construct of the AR transactivation domain (AF1*, AR residues 142-448, Fig. 1a ) that contains two known functional subdomains, transcriptional activation units 1 and 5 (Tau-1 and 5) (Callewaert et al., 2006; De Mol et al., 2016) . AF1* is intrinsically disordered with regions of helical propensity within the structurally independent Tau-1 and Tau-5 subdomains (De Mol et al., 2016 ). We measured 2D 1 H, 15 N-HSQC NMR spectra of AF-1* in the presence and in the absence of RAP74-CTD (RAP74 residues 450-517) (Lavery and McEwan, 2008a) and observed chemical shift perturbations in a region of Tau-5 with the sequence   431   SSWHTLFTAEEGQLYG 446 (Fig. 1b) . To confirm that the interaction does not involve residues in Tau-1 we repeated the experiments with a shorter AR construct (Tau-5*, AR residues 330-448) and obtained an equivalent result (Fig. S1a) .
In order to estimate the stability of the complex we performed a titration of Tau-5* with RAP74-CTD at 278 K (Fig. 1c) and found that the affinity between these two proteins was in the mM range (KD = 1749 ± 60, Fig. S1b ). This is in agreement with the notion that the protein-protein interactions that activate transcription are weak due to their multivalent and transient nature (Melcher, 2000; Pollock and Gilman, 1997; Uesugi et al., 1997) . To investigate whether binding of RAP74-CTD induces a conformational change in Tau-5 we compared the   13   Cα chemical shifts of Tau-5* in the presence and in the absence of its binding partner (RAP74-CTD*, see STAR Methods) by using 3D HNCA NMR experiments (Fig. 1d) . We observed increases in 13 Cα chemical shift in several residues of the motif, in agreement with the induction of a helical conformation (Neal et al., 2003) , which were particularly large (ca. 0.5 ppm) for residues S432 to T438, that define two turns of an α-helix (Fig. 1e) . (Fig. 2a,b) , which define the binding groove for two intrinsically disordered motifs of FCP1 that fold into an α-helix upon binding ( Fig.   2c ) (Kamada et al., 2001 (Kamada et al., , 2003 Nguyen et al., 2003a Nguyen et al., , 2003b Yang et al., 2009 ). FCP1 is a nuclear phosphatase that dephosphorylates the C-terminal domain of RNA polymerase II and is recruited by RAP74-CTD at the termination of transcription (Archambault et al., 1997 ).
An analysis of the sequences of the disordered motifs of FCP1 ( Fig. 2d) and their conservation across different species shows that the RAP74-CTD groove can accommodate different interaction motifs when they fulfill a set of requirements summarized in two consensus sequences (centFCP1 and cterFCP1) (Abbott et al., 2005; Yang et al., 2009) . This emphasizes that the interaction with RAP74 relies both on electrostatic interactions involving acidic residues at the N-terminus and at the center of the interacting motif and on hydrophobic interactions involving hydrophobic residues at relative positions i/i+3/i+4, which are buried in the interface ( Fig. 2c ) (Kamada et al., 2001 (Kamada et al., , 2003 Nguyen et al., 2003a Nguyen et al., , 2003b Yang et al., 2009 ).
The motif that we had identified in the Tau-5 sub-domain of AR partially fulfills the requirements summarized in centFCP1 and cterFCP1 (Fig. 2d) 
Helical propensity and phosphorylation state determine the stability of the complex
The interaction between specific transcription factors and general transcription regulators can be enhanced by the binding of transcriptional co-activators (Fuxreiter et al., 2008) and by posttranslational modifications (Gioeli and Paschal, 2012) . The binding of transcriptional coactivators can induce secondary structures in transactivation domains that facilitate their interaction with the basal transcription machinery by decreasing the entropic cost of folding upon binding (Lavery and McEwan, 2008a) . Post-translational modifications can either stabilize the structural changes induced by binding (Bah et al., 2015) or directly stabilize the relevant complex (Bah and Forman-Kay, 2016) . We used NMR to measure the affinity between RAP74-CTD and chemically modified peptides spanning the AR interaction motif. This experimental setup allowed us to mimic the site-specific phosphorylations that occur during AR activation as well as, by hydrocarbon stapling (Schafmeister et al., 2000) , the helical secondary structure caused for example by co-activator binding.
The regions at the N-terminus of the FCP1 motifs are rich in acidic side chains. However, the equivalent region in AR, which binds to RAP74-CTD with lower affinity, is instead rich in Ser residues (   421   GSGSPSAAASSS   432 , Fig. 2d ). We hypothesized that phosphorylation of this region contributes to stabilizing the transient complex that it forms with RAP74-CTD. An analysis of the known phosphosites of AR revealed that S424 becomes phosphorylated upon AR activation (Gioeli and Paschal, 2012) . To determine whether this phosphorylation increases the stability of the transient complex we measured the affinity for RAP74-CTD of a peptide phosphorylated on this position (pS424, Fig. 3a ,b,c). The results indicated that phosphorylation of Ser 424 increased the affinity of the peptide from KD = 1749 ± 60 to KD = 702 ± 8 μM.
As shown in Figure 2d an additional difference between the FCP1 and AR motifs is the helical propensity of the sequences. Whereas the central and C-terminal motifs of FCP1 have some helical propensity according to the predictor Agadir (Muñoz and Serrano, 1994) (15 and 38%) the AR motif has not (<1 %), in agreement with our characterization of the structural properties of the NTD of AR (De Mol et al., 2016) . Given that binding to the groove defined by helices H2
and H3 of RAP74-CTD involves the adoption of a helical conformation by the intrinsically disordered motif (Figs. 1d and e, 2c and 1c) we hypothesized that the low helical propensity of the AR motif contributes to its low affinity for RAP74-CTD.
To determine the effect of increasing the helicity we used hydrocarbon stapled peptides (Hel and pS424Hel, Fig. 3a ) where residues Thr 435 and Ala 439, which are in the face of the helix opposite the hydrophobic residues that interact with RAP74 ( Fig. 3d) , were replaced by (S)-2-(4'-pentenyl)alanine and stapled by olefin metathesis (Schafmeister et al., 2000) . A comparison of the secondary structure of the WT and Hel peptides by circular dichroism (CD) (Fig. 3e) confirmed that stapling indeed increased the helical propensity of the AR motif. We analyzed the chemical shift perturbations caused in RAP74-CTD by Hel and pS424Hel, a stapled peptide including also the phosphorylation at S424, and confirmed that both peptides interacted with higher affinity compared to their non-stapled counterparts (KD = 125 ± 3 μM for Hel and KD = 105 ± 2 μM, for pS424Hel, Fig. 3a ,b,c). These results confirm that phosphorylation facilitates binding of the AR motif to RAP74 and that processes that increase helical propensity can potentially enhance AR transcriptional activity.
The interaction can be observed in cells and contributes to AR transcriptional activity
Although it is well-established that TFIIF and the RAP74-CTD domain in particular interact with the AF1 domain of AR in vitro (Kumar et al., 2004; Lavery and McEwan, 2008b; McEwan and Gustafsson, 1997; Reid et al., 2002) there is little evidence that the interaction occurs in cells.
To investigate this we initially used biochemical techniques such as co-immunoprecipitation, but failed to detect robust interaction presumably due to its transient nature. We next used the proximity ligation assay (PLA) (Söderberg et al., 2006) , an immunofluorescence-based technique that allows the detection of proteins in close proximity inside cells. (Fig. 3g ).
Discussion
The interactions between transactivation domains of specific transcription factors and transcriptional co-activators or general transcription regulators are amongst the best characterized examples of complexes involving intrinsically disordered proteins (Brzovic et al., 2011; Di Lello et al., 2006; Feng et al., 2009; Uesugi et al., 1997) . Key features of these, which are present in the interaction studied in this work, include the induction of secondary structure in the transactivation domain upon interaction, their relatively weak nature and the important role played by post-translational modifications in their regulation (Fuxreiter et al., 2008) .
The interaction between AR and the C-terminal domain of subunit 1 of TFIIF is mediated by hydrophobic interactions between residues at positions i/i+3/i+4 of the AR motif and a hydrophobic cleft on the surface of RAP74-CTD, with an important contribution of electrostatic interactions between acidic residues in the former and basic ones in the latter. This relative position of hydrophobic residues in the AR motif is common in transactivation domains (Brzovic et al., 2011; Di Lello et al., 2006; Feng et al., 2009; Uesugi et al., 1997) , indicating that there could be a generic mechanism by which these domains recruit their binding partners at the initiation of transcription and highlighting the general importance of regulatory mechanisms to provide binding specificity. We provide evidence both in vitro and in cells that the phosphorylation of Ser 424 is important for the interaction between AR and RAP74-CTD and for AR transcriptional activity, illustrating how post-translational modifications can enhance the affinity and the specificity of intrinsically disordered proteins for their binding partners (Stein and Aloy, 2008) .
Our results indicate that AR and FCP1 interact with the same groove in the structure of RAP74-CTD via similar motifs. The interaction between AR and RAP74-CTD is, as we have shown, important for transcription initiation whereas that between the latter and FCP1 is important for transcription termination (Archambault et al. 1997) . The role of FCP1 in termination, which is carried out by its phosphatase domain, is to dephosphorylate the C-terminal tail of RNA polymerase II, causing it to dissociate from the DNA and therefore allowing it to become involved in a subsequent round of transcription. We conclude that RAP74-CTD, which is a particularly dynamic part of the transcription machinery and is tethered to it via a very flexible the whole Tau-5 sub-domain after co-activator binding (Fuxreiter et al., 2008) or the effect of extrinsic factors that cannot be easily accounted for by in vitro studies. It is in fact possible that several of these mechanisms operate simultaneously as they would provide an efficient means of regulating transcriptional activity (Hilser and Thompson, 2011; Wu and Fuxreiter, 2016) .
The relevance of Tau-5, the sub-domain of the AR NTD where the 431 SSWHTLFTAEEGQLYG 446 motif is found, for transcriptional activity in cells depends on the cell line used for the experiments and on the concentration of androgens to which the cells are exposed. Tau-5 inhibits transcriptional activity in prostate cancer cell lines expressing AR in the presence of physiological concentrations of androgens (Dehm et al., 2007) . By contrast it stimulates transcriptional activity in cell lines that do not express AR (Jenster et al. 1995) and, most importantly, in CRPC cell lines expressing AR in the absence androgens or in their presence at castrate levels, where residues 433 to 437, at the core of the motif identified in this work, can act as independent transactivation domain (Dehm et al., 2007) .
From a translational medicine point of view our results and those available in the literature indicate therefore that the motif that recruits RAP74-CTD can contribute to transcription activation by AR and, therefore, that the complex that it forms with this subunit of TFIIF is a potential therapeutic target for CRPC, although we cannot exclude the possibility that other interactions contribute to its function in transcription activation (Cato et al., 2017; He et al., 2000; Li et al., 2014) . In summary, although protein-protein interactions involving intrinsically disordered proteins represent challenging targets for drug discovery our work indicates that inhibitors of the recruitment of RAP74-CTD by AR, which could be either small molecules or peptides, could lead to new treatments for prostate cancer and, especially, CRPC (Yap et al., 2016) . 
STAR Methods
Protein expression and purification
RAP74-CTD* was obtained as previously reported (Lavery and McEwan, 2008b) °C. The HisMBP moiety and the uncleaved material were removed by reverse Ni 2+ chromatography, which was followed by cationic exchange and size exclusion chromatography steps. AF-1* and Tau-5* were produced following procedures previously reported (De Mol et al., 2016) .
Peptides
The synthesis of the peptides used in this work was performed by GenScript (pS424, Hel) analyzed with a 63× objective on a Leica SP5 or SPE confocal microscopes.
Transcriptional activity assay
To assess AR-mediated transcriptional activity on the Prostate Specific Antigen (PSA) promoter, HEK293T cells were co-transfected with pCMV5-flag-AR WT or mutants, pTK-Renilla and PSA (6.1)-Luc plasmids, and 48 hours later were treated with 1 nM DHT for 24 hours. Samples were assayed for luciferase activity using the Dual-Luciferase Reporter Assay System (Promega)
according to manufacturer's instructions. pTK-Renilla was used for normalization of luciferase 
